Home » Topics » BioWorld Science

BioWorld Science
RSS

RedCloud cleared to enter clinic with next-generation EGFR inhibitor H-002 for NSCLC

March 3, 2022

NTLA-2002 shows promising preclinical results in a partial hepatectomy-induced HAE model

March 3, 2022

Novel propolis-derived CREB/CRTC2 inhibitor ameliorates metabolic syndrome in obese mice

March 3, 2022

BBP-671 restores brain glutamate/glutamine levels in preclinical model of coenzyme A deficiency

March 3, 2022

Immunotherapies targeting WT137-45 may avoid acute myeloid leukemia immune evasion

March 3, 2022

Eoetvoes Lorand Tudomanyegyetem, Semmelweis University patent imipridone derivatives

March 3, 2022

Roche divulges new TLR7/8/9 antagonists

March 3, 2022

Ruhr University Bochum presents new compounds for treating axonal damage

March 3, 2022

New SLC10A2/SLC10A1 inhibitors identified at Albireo

March 3, 2022

Sitryx Therapeutics describes nuclear factor erythroid 2-related factor 2 activators

March 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...